title: What length of follow-up in patients with HIV and hepatitis C virus coinfection is necessary to consider the level of transaminases to be "persistently normal"?
authors.forename: P
authors.initials: P
authors.lastname: Pérez-Guerrero
authors.forename: M J
authors.initials: MJ
authors.lastname: Blanco
authors.forename: C
authors.initials: C
authors.lastname: Martínez-Sierra
authors.forename: A
authors.initials: A
authors.lastname: Arizcorreta
authors.forename: J A
authors.initials: JA
authors.lastname: Girón-González
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications* / Q000201:enzymology*; D006526:Hepatitis C / Q000150:complications* / Q000201:enzymology*; D006801:Humans; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D012016:Reference Values; D013997:Time Factors; D000637:Transaminases / Q000097:blood*
chemical_list: D000637:Transaminases